Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracavernous PRP for Erectile Dysfunction
NCT06942988Phase 3Active, not recruiting
- Sponsor
- Bakırköy Dr. Sadi Konuk Research and Training Hospital
- Start
- Dec 2023
- Primary completion
- Jul 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of platelet-rich plasma in erectile dysfunction (ED), sponsored by Bakırköy Dr. Sadi Konuk Research and Training Hospital. Primary endpoint: International Index of Erectile Function at 6 months. Started Dec 2023; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06942988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06942988.